Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-13 5:13 pm Unchanged | 13G | Celularity Inc. CELU | STARR INTERNATIONAL CO INC | 15,281,389 10.54% | 0 (Unchanged) | View |
| 2023-02-13 5:12 pm Purchase | 13G | Celularity Inc. CELU | C V STARR & CO INC | 7,640,693 5.27% | 7,640,693 (New Position) | View |
| 2023-02-06 06:01 am Unchanged | 13G | Celularity Inc. CELU | UNITED THERAPEUTICS Corp UTHR | 7,968,848 5.5% | 0 (Unchanged) | View |
| 2023-02-03 07:28 am Purchase | 13G | Celularity Inc. CELU | UNITED THERAPEUTICS Corp UTHR | 7,968,848 6.51% | 7,968,848 (New Position) | View |
| 2022-02-04 12:07 pm Unchanged | 13G | Celularity Inc. CELU | Weiss Asset Management LP | 0 0% | 0 (Unchanged) | View |
| 2022-01-27 08:13 am Unchanged | 13G | Celularity Inc. CELU | HIGHBRIDGE CAPITAL MANAGEMENT LLC | 0 0% | 0 (Unchanged) | View |
| 2021-07-26 5:19 pm Purchase | 13G | Celularity Inc. CELU | Human Longevity Inc. | 7,012,574 5.7% | 7,012,574 (New Position) | View |
| 2021-07-26 5:16 pm Purchase | 13D | Celularity Inc. CELU | Hariri Robert J | 10,296,668 8.2% | 10,296,668 (New Position) | View |
| 2021-07-26 5:10 pm Purchase | 13G | Celularity Inc. CELU | BRISTOL MYERS SQUIBB CO BMY | 11,953,274 9.9% | 11,953,274 (New Position) | View |
| 2021-07-26 4:12 pm Purchase | 13D | Celularity Inc. CELU | Dragasac Ltd | 36,592,596 28.4% | 36,592,596 (New Position) | View |
| 2021-07-26 12:19 pm Purchase | 13G | Celularity Inc. CELU | STARR INTERNATIONAL CO INC | 15,281,389 11.8% | 15,281,389 (New Position) | View |
| 2021-07-23 06:02 am Purchase | 13G | Celularity Inc. CELU | Sorrento Therapeutics Inc. SRNEQ | 20,422,124 16.7% | 20,422,124 (New Position) | View |
| 2021-07-15 1:21 pm Sale | 13G | GX Acquisition Corp. GXGX | Feis Lawrence | 0 0% | -1,455,253 (Position Closed) | View |
| 2021-07-08 3:49 pm Purchase | 13G | GX Acquisition Corp. GXGX | Feis Lawrence | 1,455,253 11.57% | 815,236 (+127.38%) | View |
| 2021-06-01 5:13 pm Purchase | 13G | GX Acquisition Corp. GXGX | HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,584,052 5.51% | 1,584,052 (New Position) | View |
| 2021-05-27 12:40 pm Purchase | 13G | GX Acquisition Corp. GXGX | Feis Lawrence | 640,017 5.09% | 640,017 (New Position) | View |
| 2021-03-31 2:21 pm Purchase | 13G | GX Acquisition Corp. GXGX | Weiss Asset Management LP | 2,446,179 8.51% | 2,446,179 (New Position) | View |
| 2021-02-16 06:04 am Sale | 13G | GX Acquisition Corp. GXGX | RP Investment Advisors LP | 0 0% | -1,653,259 (Position Closed) | View |
| 2021-02-09 08:47 am Sale | 13G | GX Acquisition Corp. GXGX | Polar Asset Management Partners Inc. | 267,128 0.93% | -1,932,872 (-87.86%) | View |
| 2021-02-01 06:31 am Sale | 13G | GX Acquisition Corp. GXGX | Linden Capital L.P. | 517,767 1.8% | -2,058,233 (-79.90%) | View |